BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11742319)

  • 1. Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancer.
    Eigelberger MS; Wong MG; Duh QY; Clark OH
    Surgery; 2001 Dec; 130(6):931-5. PubMed ID: 11742319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function.
    Kebebew E; Wong MG; Siperstein AE; Duh QY; Clark OH
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2840-7. PubMed ID: 10443689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells.
    Yuan GB; Kuang AR; Fan Q; Yu LB; Mi YX
    Chin J Cancer; 2010 Apr; 29(4):379-84. PubMed ID: 20346212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
    Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
    Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines.
    Trojanowicz B; Winkler A; Hammje K; Chen Z; Sekulla C; Glanz D; Schmutzler C; Mentrup B; Hombach-Klonisch S; Klonisch T; Finke R; Köhrle J; Dralle H; Hoang-Vu C
    J Mol Endocrinol; 2009 Mar; 42(3):249-60. PubMed ID: 19060179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
    Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
    Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
    Schreck R; Schnieders F; Schmutzler C; Köhrle J
    J Clin Endocrinol Metab; 1994 Sep; 79(3):791-8. PubMed ID: 8077363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
    Hoelting T; Siperstein AE; Duh QY; Clark OH
    J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
    Hoelting T; Siperstein AE; Clark OH; Duh QY
    J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
    Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
    Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
    Hoelting T; Duh QY; Clark OH; Herfarth C
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
    Cras A; Darsin-Bettinger D; Balitrand N; Cassinat B; Soulié A; Toubert ME; Delva L; Chomienne C
    Oncogene; 2007 Jun; 26(27):4018-24. PubMed ID: 17213810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer.
    Clinckspoor I; Verlinden L; Overbergh L; Korch C; Bouillon R; Mathieu C; Verstuyf A; Decallonne B
    J Steroid Biochem Mol Biol; 2011 Mar; 124(1-2):1-9. PubMed ID: 21182945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom.
    Schmutzler C; Brtko J; Bienert K; Köhrle J
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():16-9. PubMed ID: 8980993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of all-trans retinoic acid and sodium butyrate in vitro and in vivo on thyroid carcinoma xenografts.
    Massart C; Denais A; Gibassier J
    Anticancer Drugs; 2006 Jun; 17(5):559-63. PubMed ID: 16702813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells.
    Sidell N; Pasquali M; Malkapuram S; Barua AB; Wanichkul T; Wada RK
    Br J Cancer; 2003 Jul; 89(2):412-9. PubMed ID: 12865937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
    Marth C; Daxenbichler G; Dapunt O
    J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.